Lung, D702BC00001 “Artemide-Lung02”

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum-based Chemotherapy for the First-line Treatment of Patients with Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1

Esophageal, TP-CA-007 “Aries”

A Biobank Registry Platform Study in Oncology Patients with advanced or metastatic disease (Stage 3B, 3C, 4) gastric, esophageal, or gastroesophageal junction (GEJ) cancer

Colorectal, MCLA-158-CL01 “MERUS”

Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158 (petosemtamab) as single agent or in combination in mCRC

Breast, A012301 "LOTAM"

A randomized phase III clinical trial of low-dose Tamoxifen for selected patients with molecular low-risk early-stage breast cancer.

Women's Cancer - Prevention & Treatment

CLICK HERE TO REGISTER

Yin & Sound - April 23

Spring Sound Bath

Patient Newsletter 2025 March

Cancer Q&A with HOA: Colorectal Cancer Awareness Month

Profile of Danielle Maciorowski, PharmD - Pharmacy Educator

March 2025 Family Times Educator Profile

1. What inspired you to pursue a career in pharmacy, particularly in hematology and oncology—and what ultimately led you to join Hematology-Oncology Associates of CNY (HOA)?

Pages